Pharmafile Logo

New appointments in our UK and New York offices

Research Partnership is delighted to announce various appointments across our offices. Ella Buckland joins as Research Executive, Ines Belchior joins as Research Analyst, and Emma Warburton joins as Business Development Executive, all three to be based in the UK headquarters. Aaron Platt joined as Senior Research Executive and Dominika Klubek joined as Research Manager, both within the MedTech team and Austin Andrews joined as Research Analyst – they will reside in the New York office…

Ella, who studied Chemistry at the University of Bath, has experience working in market research across a range of immunology diseases, specifically in dermatology. Ines has previous experience conducting social and market research in a communications and strategy consultancy. She studied International Politics at City, University of London.
Emma has previous experience working as a pricing and market research analyst. She studied global health and received a master’s degree in international health policy from London School of Economics.

Austin Andrews attended Bucknell University in Pennsylvania where he got his B.A. in Biology and Psychology.

Aaron Platt received his undergraduate degree in sociology from New York University and his master’s degree in sociology from the University of California, Berkeley, where he is also currently working on his doctoral dissertation. He has worked in social science research, both quantitative and qualitative, for 11 years, working on projects for pharmaceutical and healthcare-related non-profit organisations.

Dominika has previous experience in leading primarily quant studies across a broad range of industries from consumer health to CPG and retail. She worked at Lieberman Research for 5 years with a strong focus in pharmaceuticals. Dominika has her master’s degree in industrial and organizational psychology from Hofstra University in Long Island.

Jon Ford has joined the London headquarters as in-house Recruitment Consultant, a newly created role to support demand for additional talent. He previously spent 4 years at Trace Recruitment where he focused on head hunting and recruitment in the Market Research and Brand Strategy sectors.

Speaking about the new appointments, Founding Director Mary Assimakopoulos said, “We are delighted to welcome our new hires and look forward to making further recruitment announcements in the near future .”

Find out more about a career with us »

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

How will AI change field training?

Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.

MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...

Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.

Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

How DataGateway unified oncology data for real-world insights & market intelligence

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

Preparing for ASH 2025: Pharma’s role in hematology innovation

As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies...

AI without limits: A smarter, integrated approach to Medical Affairs

At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless...